DE213459C - - Google Patents
Info
- Publication number
- DE213459C DE213459C DE1908213459D DE213459DA DE213459C DE 213459 C DE213459 C DE 213459C DE 1908213459 D DE1908213459 D DE 1908213459D DE 213459D A DE213459D A DE 213459DA DE 213459 C DE213459 C DE 213459C
- Authority
- DE
- Germany
- Prior art keywords
- acid
- aminobenzoic acid
- propyl
- propyl ester
- aminobenzoic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 15
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 15
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- KXUOYHZSTGGNCK-UHFFFAOYSA-N propyl 4-nitrobenzoate Chemical compound CCCOC(=O)C1=CC=C([N+]([O-])=O)C=C1 KXUOYHZSTGGNCK-UHFFFAOYSA-N 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000003444 anaesthetic Effects 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- -1 n-propyl radical Chemical class 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N Guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- NBFQYHKHPBMJJV-UHFFFAOYSA-N Risocaine Chemical compound CCCOC(=O)C1=CC=C(N)C=C1 NBFQYHKHPBMJJV-UHFFFAOYSA-N 0.000 description 2
- 150000005415 aminobenzoic acids Chemical class 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 125000004492 methyl ester group Chemical group 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- OTLNPYWUJOZPPA-UHFFFAOYSA-N 4-Nitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C=C1 OTLNPYWUJOZPPA-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N Benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 210000001772 Blood Platelets Anatomy 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N Carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N Ethyl radical Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 229960001867 Guaiacol Drugs 0.000 description 1
- 229960004873 LEVOMENTHOL Drugs 0.000 description 1
- 229940041616 Menthol Drugs 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N Methyl radical Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- VNQABZCSYCTZMS-UHFFFAOYSA-N Orthocaine Chemical compound COC(=O)C1=CC=C(O)C(N)=C1 VNQABZCSYCTZMS-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- MGSRCZKZVOBKFT-UHFFFAOYSA-N Thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000171 higher toxicity Toxicity 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- ZTHYODDOHIVTJV-UHFFFAOYSA-N propyl 3,4,5-trihydroxybenzoate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 229930007823 thymol Natural products 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT48642D AT48642B (de) | 1908-03-24 | 1909-03-29 | Verfahren zur Darstellung des n-Propylesters der p-Aminobenzoesäure. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE213459C true DE213459C (US08188275-20120529-C00054.png) |
Family
ID=475105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1908213459D Expired - Lifetime DE213459C (US08188275-20120529-C00054.png) | 1908-03-24 | 1908-03-24 |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE213459C (US08188275-20120529-C00054.png) |
-
1908
- 1908-03-24 DE DE1908213459D patent/DE213459C/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1179556B (de) | Verfahren zur herstellung von freiem oder acyliertem n-(4-diäthylaminobutyl)-salicyclsäureamid | |
| DE213459C (US08188275-20120529-C00054.png) | ||
| DE539403C (de) | Verfahren zur Darstellung von N-Halogenacylarylsulfamiden | |
| DE194810C (US08188275-20120529-C00054.png) | ||
| DE234741C (US08188275-20120529-C00054.png) | ||
| DE1076704B (de) | Verfahren zur Herstellung von therapeutisch verwendbaren Carbonsaeurederivaten | |
| AT215972B (de) | Verfahren zur Herstellung von neuen, eine Dreifachbindung enthaltenden ungradzahligen Fettsäuren und deren Salzen | |
| DE763489C (de) | Verfahren zur Herstellung von ª-Aminoaethylestern substituierter Phenylessigsaeuren | |
| DE206055C (US08188275-20120529-C00054.png) | ||
| DE117625C (US08188275-20120529-C00054.png) | ||
| DE964326C (de) | Verfahren zur Herstellung von Derivaten des 4-Oxycumarins | |
| DE414190C (de) | Verfahren zur Darstellung von Zitronensaeuretribenzylester | |
| DE1793426C (de) | alpha Phenoxyisobuttersaure ester und Verfahren zu ihrer Her stellung | |
| DE576445C (de) | Verfahren zur Herstellung von Primulasaeure (Primulasaponin) aus Primulaarten | |
| AT214450B (de) | Verfahren zur Herstellung von d-2-Phenyl-3-methyltetrahydro-1,4-oxazin | |
| AT33448B (de) | Verfahren zur Darstellung von Aminoalkylestern. | |
| DE619348C (de) | Verfahren zur Herstellung von reinem Diacetyl aus Holzessig oder anderen Diacetyl enthaltenden Gemischen | |
| AT214910B (de) | Verfahren zur Herstellung von neuen, am Stickstoffatom und am β-Kohlenstoffatom substituierten Buttersäureamiden | |
| DE561314C (de) | Verfahren zur Herstellung von leicht loeslichen Salzen hochmolekularer jodierter Fettsaeuren | |
| DE704297C (de) | Verfahren zur Darstellung von neutralen, oelloeslichen und sterilisierbaren organischen Wismutsalzen | |
| DE495336C (de) | Verfahren zur Darstellung von basischen Oximaethern und ihren Salzen | |
| DE2420153C3 (de) | Arzneimittel mit lokalanästhetischer Wirkung | |
| AT215414B (de) | Verfahren zur Herstellung von neuen β-Hydroxybuttersäureamid-Derivaten | |
| DE1770273A1 (de) | Neue basische Ketone | |
| DE1200832B (de) | Verfahren zur Herstellung von 3, 5-Dijodthyroninderivaten |
